Self-nanoemulsfiying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis
Open Access
- 1 September 2018
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 13, 5887-5907
Abstract
Background: Bruceine D (BD) is a major bioactive component isolated from the traditional Chinese medicinal plant Brucea javanica which has been widely utilized to treat dysentery (also known as ulcerative colitis [UC]). Methods: To improve the water solubility and absolute bioavailability of BD, we developed a self-nanoemulsifying drug delivery system (SNEDDS) composing of MCT (oil), Solutol HS-15 (surfactant), propylene glycol (co-surfactant) and BD. The physicochemical properties and pharmacokinetics of BD-SNEDDS were characterized, and its anti-UC activity and potential mechanism were evaluated in TNBS-induced UC rat model. Results: The prepared nanoemulsion has multiple beneficial aspects including small mean droplet size, low polydispersity index (PDI), high zeta potential (ZP) and excellent stability. Transmission electron microscopy showed that nanoemulsion droplets contained uniform shape and size of globules. Pharmacokinetic studies demonstrated that BD-SNEDDS exhibited enhanced pharmacokinetic parameters as compared with BD-suspension. Moreover, BD-SNEDDS significantly restored the colon length and body weight, reduced disease activity index (DAI) and colon pathology, decreased histological scores, diminished oxidative stress, and suppressed TLR4, MyD88, TRAF6, NF-κB p65 protein expressions in TNBS-induced UC rat model. Conclusion: These results demonstrated that BD-SNEDDS exhibited highly improved oral bioavailability and advanced anti-UC efficacy. In conclusion, our current results provided a foundation for further research of BD-SNEDDS as a potential complementary therapeutic agent for UC treatment.Keywords
This publication has 79 references indexed in Scilit:
- Involvement of MAPK/NF-κB Signaling in the Activation of the Cholinergic Anti-Inflammatory Pathway in Experimental Colitis by Chronic Vagus Nerve StimulationPLOS ONE, 2013
- Bioavailability enhancers of herbal origin: An overviewAsian Pacific Journal of Tropical Biomedicine, 2013
- Kinetic Analysis of the Toxicity of Pharmaceutical Excipients Cremophor EL and RH40 on Endothelial and Epithelial CellsJournal of Pharmaceutical Sciences, 2013
- Involvement of the mitochondrial pathway in bruceine D-induced apoptosis in Capan-2 human pancreatic adenocarcinoma cellsInternational Journal of Molecular Medicine, 2012
- Nanomedicine in GIAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Mechanism of Regulation of Na-H Exchanger in Inflammatory Bowel Disease: Role of TLR-4 Signaling MechanismDigestive Diseases and Sciences, 2011
- High-concentration zeta potential measurements using light-scattering techniquesPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2010
- 6‐Shogaol suppressed lipopolysaccharide‐induced up‐expression of iNOS and COX‐2 in murine macrophagesMolecular Nutrition & Food Research, 2008
- Protection from experimental colitis by theaflavin‐3,3′‐digallate correlates with inhibition of IKK and NF‐κB activationBritish Journal of Pharmacology, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004